BIO and Indiana Health Industry Forum commend Indiana State Senate for passing legislation designed to create pathway for the substitution of interchangeable biologic medicines. Legislation ensures transparency and communication between patients and their treatment teams. Policies outlined in the identical SB 262 align with BIO’s principles on biologic substitution, therefore BIO and IHIF support passage of this bill as it moves along for consideration by the Indiana House of ...This story is related to the following:Trade Associations